摘要
N6-methyladenosine (m6A) RNA modification has recently emerged as an essential regulator of normal and malignant hematopoiesis. As a reversible epigenetic modification found in messenger RNAs and non-coding RNAs, m6A affects the fate of the modified RNA molecules. It is essential in most vital bioprocesses, contributing to cancer development. Here, we review the up-to-date knowledge of the pathological functions and underlying molecular mechanism of m6A modifications in normal hematopoiesis, leukemia pathogenesis, and drug response/resistance. At last, we discuss the critical role of m6A in immune response, the therapeutic potential of targeting m6A regulators, and the possible combination therapy for AML.
学科与关键词
关键词
N6-methyladenosine RNA modificationAcute myeloid leukemiaImmunomodulationTargeted therapy
- The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implicationsLiu, Ziying; Gao, Lei; Cheng, Long; Lv, Gaoyuan; Sun, Bei; Wang, Gang*; Tang, Qiushi*Experimental and Molecular Medicine, 2023, 55(3): 487-501.被引 5
- Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escapeLi, Wei; Hao, Yi; Zhang, Xingda; Xu, Shouping*; Pang, Da*Molecular Cancer, 2022, 21(1): 176.被引 12
- Crosstalk Between Histone and m6A Modifications and Emerging Roles of m6A RNA MethylationXu, Zibin; Xie, Tingfei; Sui, Xiaolu; Xu, Yunpeng; Ji, Lecai; Zhang, Yanzi; Zhang, Aisha; Chen, Jihong*Frontiers in Genetics, 2022, 13: 908289.被引 4
